Search results
Scott L. Pomeroy is the Bronson Crothers Professor of Neurology and Director of the Intellectual and Developmental Disabilities Research Center of Harvard Medical School, Chairman of the Department of Neurology and Neurologist-in-Chief of Boston Children's Hospital, and an Associate Member of the Broad Institute of MIT and Harvard .
MD, PhD. Neurologist-in-Chief, Chairman, Department of Neurology. Bronson Crothers Professor of Neurology, Harvard Medical School. Request an Appointment View Research Profile. Phone: 617-355-6386. Fax: 617-730-0284. NPI: 1235158668. Print Profile.
A highly effective teacher, scholar, administrator, and leader within the field of child neurology, his primary focus is the field of pediatric neuro-oncology. Scott entered the world in Cincinnati, where he spent his childhood and adolescence.
Scott L. Pomeroy, MD, PhD. Neurologist-in-Chief, Boston Children's Hospital. Bronson Crothers Professor in Neurology, Harvard Medical School. Appointment Phone. 888-733-4662 (New Pediatric Patients) 617-632-3270 (Established Pediatric Patients) Fax. 617-730-0286.
Dr. Scott L. Pomeroy is a Pediatric Neurologist in Boston, MA. Find Dr. Pomeroy's phone number, address, insurance information, hospital affiliations and more.
He currently is the Neurologist-in-Chief of Boston Children's Hospital and the Director of the Intellectual and Developmental Disabilities Research Center of Boston Children's Hospital and Harvard Medical School.
Scott Pomeroy, MD, PhD. Bronson Crothers Professor of Neurology, Harvard Medical School. Neurologist-in-Chief, Kirby Center, Boston Children's Hospital.
Neurologist-in-Chief, Boston Children's Hospital. Bronson Crothers Professor in Neurology, Harvard Medical School.
Scott Pomeroy is the Bronson Crothers Professor of Neurology and Director of the Intellectual and Developmental Disabilities Research Center of Harvard Medical School, and since 2005 Chairman of the Department of Neurology and Neurologist-in-Chief of Boston Children’s Hospital.
Scott L. Pomeroy is one of the world s leading experts on pediatric brain cancer. His group was first to identify genetic markers that predict treatment response of medulloblastomas, the most common malignant brain tumor in children; he was among the first to apply genomic methods to studying childhood cancer.
